Vitiligo Market Research Report and Company Analysis 2024-2032 Featuring Incyte, BMS, Clinuvel, Astellas Pharma, Baxter International, Pfizer, and Dr. Reddy's Laboratories
August 30, 2024 04:11 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Vitiligo Market Report, Forecast by Diseases Type, Treatment Type, End User, Countries and Company Analysis, 2024-2032" report has been added to ...
Vitiligo Therapeutic Assessment Analysis Report 2024: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs Featuring Key Players - AbbVie, Pfizer, Incyte, Ahammune Biosciences, & Amgen
July 17, 2024 10:12 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Vitiligo - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Vitiligo - Pipeline Insight, 2024" report...
Global Vitiligo Treatment Market 2023: Unpacking the Potential of Antihistamines, H2 Antagonists and Tricyclic Antidepressants
October 30, 2023 05:43 ET
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment Global Market Report 2023" has been added to ResearchAndMarkets.com's offering. The global vitiligo treatment market is expected...
Vitiligo Treatment Global Market to Reach $822.75 by 2028: Players Include Incyte, Bristol-Myers Squibb and Clinuvel Pharmaceuticals
September 06, 2023 09:58 ET
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report...